Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Region Stockholm
Beth Israel Deaconess Medical Center
National and Kapodistrian University of Athens
Massachusetts General Hospital
Medical University of Gdansk
Duke University